is diarrhea a symptom of glp 1 Starting GLP-1 medication? Knowing the common side effects can help you navigate your health journey smoothly. Tap below to for the full guide: https://bit.ly/4obf3qk Staying properly hydrated while taking

Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research

In December 2024, Eli Lilly, the US pharmaceutical giant, announced the launch of its blockbuster drug, Tirzepatide, in India in 2025

Nexa offers compounded GLP-1 (Semaglutide) prepared by licensed pharmacies for patients who qualify

Freitas S, Merkle HP, Gander B

Tirzepatide (Dual Agonist) Technically a dual GIP/GLP-1 receptor agonist, this drug acts on both GLP-1 and GIP receptors for potentially higher efficacy

Market Segmentation Global Glucagon-Like Peptide-1 Agonists Market Size, Share & Industry Analysis, By Product Type (Short-Acting GLP-1 Agonists, Long-Acting GLP-1 Agonists), By Route of Administration (Injectable, Oral), By Application (Type 2 Diabetes, Obesity Management, Cardiovascular Disease Management), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 20262035 Global Glucagon-Like Peptide-1 Agonists Market Size & Statistics The Market size of global glucagon-like peptide-1 agonists was estimated to be worth USD 46.18 Billion in 2025